The CGTLive™ Dermatology specialty topic page contains clinical news coverage of the latest updates on cell therapies, gene therapies, and engineered and regenerative medicines developed for dermatological skin conditions. It also houses video interviews with key opinion leaders in the field of dermatology to keep you up to date about the latest relevant FDA actions, clinical guideline updates, and clinical trial findings.
April 29th 2025
The agency's decision was based on data from the phase 3 VIITAL study (NCT04227106).